Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam17 Regulatory News (TM17)

Share Price Information for Team17 (TM17)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 235.00
Bid: 230.00
Ask: 240.00
Change: 0.00 (0.00%)
Spread: 10.00 (4.348%)
Open: 235.00
High: 235.00
Low: 235.00
Prev. Close: 235.00
TM17 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

18 Jul 2018 07:00

RNS Number : 9442U
Team17 Group PLC
18 July 2018
 

18 July 2018

Team17 Group plc

("Team17", the "Group" or the "Company")

 

Trading update

 

Team17, a global games label, creative partner and developer of independent ("indie"), premium video games, is pleased to provide an update for the six months ended 30 June 2018.

 

The Company has made a strong start to 2018 and expects to deliver full year results in line with market expectations.

 

The Company's back catalogue continues to perform well and H1 saw the launch of a small number of new IP from label partners, including My Time At Portia by Pathea Games, Team17's first indie partner in China. My Time At Portia has successfully launched in early access on PC and illustrates the capabilities and infrastructure of our publishing teams to support global partners.

 

In June 2018, the Company announced the launch date of Overcooked 2, the sequel to the double BAFTA-winning game on Xbox One, PlayStation 4, Nintendo Switch™ and PC. The game has been co-developed in partnership with indie developer Ghost Town Games and demonstrates the unique ability we provide as a creative partner. The game has seen strong traction with media ahead of the launch on 7 August 2018, and was awarded the highly prestigious 'Best of E3 2018 Game Critics Award' for Best family/social game.

 

The Company had a successful E3, one of the games industry's leading calendar events, with three games featuring in press conferences. In partnership with Nintendo, we unveiled Overcooked 2, PLANET ALPHA was featured in Microsoft's ID@Xbox montage and a new trailer for Genesis: Alpha One was revealed during the PC Gaming Show.

 

Debbie Bestwick MBE, Chief Executive Officer of Team17, commented:

 

"We are pleased with our performance in the first half of our financial year and the ongoing success of both owned and label partner IP.

 

"The announcement of Overcooked 2 and early access launch of My Time At Portia provides further evidence of our commitment to building brands and collaborating with some of the most creative indie partners around the globe.

 

"We are delighted with the reaction received globally for our games at E3. We have also recently won the 'Develop Publishing Hero' Industry award for the second time, which is further testament to the high quality premium games we select and the hard work of all of our teams who I'd like to thank.

 

"We look forward to updating our shareholders on our progress over the coming months."

 

 

 

Enquiries:

 

Team17 Group plc

Debbie Bestwick MBE, Chief Executive Officer

Paul Bray, Chief Financial Officer & Chief Operating Officer

 

via Vigo Communications

+44 (0)20 7390 0238

GCA Altium (Nominated Adviser)

Phil Adams / Adrian Reed / Paul Lines

 

+44 (0)845 505 4343

Berenberg (Broker)

Chris Bowman / Toby Flaux / Marie-Agnes Stolberg

 

+44 (0)20 3207 7800

Vigo Communications (Financial Public Relations)

Jeremy Garcia / Fiona Henson

team17@vigocomms.com

+44 (0)20 7390 0238

 

 

About Team17

 

Founded in 1990, Team17 Group plc is a leading international video games label and creative partner for independent developers. The portfolio comprises over 90 games, including The Escapists, Genesis: Alpha One, My Time At Portia, Overcooked, Yoku's Island Express, Yooka-Laylee, the Worms franchise and many more from developers around the world. Visit www.team17.com for more info.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUBRNRWUABAAR
Date   Source Headline
19th Mar 20243:29 pmRNSHoldings in Company
13th Mar 20248:30 amRNSDirector/PDMR Shareholding
1st Mar 20248:58 amRNSNotice of Results
14th Feb 20241:00 pmRNSDirector/PDMR Shareholding
13th Feb 20244:28 pmRNSDirector/PDMR Shareholding
1st Feb 20241:10 pmRNSHolding(s) in Company
29th Jan 20247:00 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSTrading Update
19th Jan 20243:01 pmRNSHolding(s) in Company
12th Jan 20244:53 pmRNSHolding(s) in Company
12th Jan 20243:04 pmRNSHolding(s) in Company
11th Jan 20243:23 pmRNSDirector/PDMR Shareholding
14th Dec 20239:15 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSDirector Dealings
27th Nov 20237:00 amRNSDirector Dealings
24th Nov 20237:00 amRNSTrading Update
15th Nov 20233:29 pmRNSHolding(s) in Company
13th Nov 20234:57 pmRNSDirector/PDMR Shareholding
30th Oct 20233:51 pmRNSHolding(s) in Company
18th Oct 202312:41 pmRNSHolding(s) in Company
11th Oct 20235:14 pmRNSDirector/PDMR Shareholding
21st Sep 20231:06 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSHalf Year Results
12th Sep 20239:00 amRNSDirector/PDMR Shareholding
22nd Aug 20237:00 amRNSBoard Update
17th Aug 20234:46 pmRNSHolding(s) in Company
14th Aug 20239:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSNotice of Results & Trading Update
19th Jul 20237:00 amRNSDirectorate Changes
18th Jul 20232:15 pmRNSDirector/PDMR Shareholding
14th Jul 20237:00 amRNSAppointment of Joint Corporate Broker
12th Jul 20233:36 pmRNSDirector/PDMR Shareholding
22nd Jun 20232:01 pmRNSResult of AGM
16th Jun 20234:27 pmRNSHolding(s) in Company
14th Jun 20238:55 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSAppointment of Group Chief Executive Officer
26th May 20237:01 amRNSBoard Update
26th May 20237:00 amRNSPosting of Annual Report and Notice of AGM
25th May 20234:42 pmRNSHolding(s) in Company
15th May 202312:50 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTeam17's astragon Acquires Independent Arts
13th Apr 20233:40 pmRNSIssue of Shares
12th Apr 20238:20 amRNSDirector/PDMR Shareholding
31st Mar 202311:15 amRNSDirector/PDMR Shareholding
28th Mar 20237:01 amRNSDirector Update
28th Mar 20237:00 amRNSUnaudited Final Results 2022
13th Mar 20234:49 pmRNSDirector/PDMR Shareholding
13th Mar 20239:05 amRNSNo Material Exposure to Silicon Valley Bank
2nd Mar 20237:00 amRNSNotice of Results & Analyst/Investor Presentations
13th Feb 20231:41 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.